HUMAN PAPILLOMAVIRUS TYPE-16-E6 INCREASES THE DEGRADATION RATE OF P53 IN HUMAN KERATINOCYTES

被引:169
|
作者
HUBBERT, NL [1 ]
SEDMAN, SA [1 ]
SCHILLER, JT [1 ]
机构
[1] NCI,CELLULAR ONCOL LAB,BETHESDA,MD 20892
关键词
D O I
10.1128/JVI.66.10.6237-6241.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The E6 proteins of the high-risk human papillomaviruses (HPVs) have been shown to form a complex with and induce the degradation of human p53 in vitro. To determine whether p53 is degraded more rapidly in cells expressing E6 in vivo, the half-life of p53 was determined by pulse-chase analysis in early-passage normal human keratinocytes and fibroblasts, human keratinocytes immortalized with HFV type 16 (HPV16) E6 plus E7, and nonimmortal keratinocytes transfected with E6. The results of these experiments indicate that (i) the half-life of newly synthesized p53 is relatively long (4 h) in early-passage human keratinocytes and fibroblasts but short in keratinocytes expressing E6 (15 to 30 min), (ii) a similar increased rate of p53 degradation was measured in lines immortalized with HPV16 E6 plus E7 and senescent cells expressing E6, indicating that this increase is not simply the result of selection in the immortalized lines, and (iii) very low levels of expression of E6 result in a greatly decreased half-life of p53, suggesting that E6 acts in a catalytic manner.
引用
收藏
页码:6237 / 6241
页数:5
相关论文
共 50 条
  • [31] MODULATION OF IMMORTALIZING PROPERTIES OF HUMAN PAPILLOMAVIRUS TYPE-16 E7 BY P53 EXPRESSION
    CROOK, T
    FISHER, C
    VOUSDEN, KH
    JOURNAL OF VIROLOGY, 1991, 65 (01) : 505 - 510
  • [32] Structure of the E6/E6AP/p53 Complex in Human Papillomavirus
    Fassler, Amy
    Bhat, Tara
    Rens, Davis
    Chojnacki, Kennan
    Neil, Uma
    FASEB JOURNAL, 2020, 34
  • [33] Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53
    Giovane, C
    Travé, G
    Briones, A
    Lutz, Y
    Wasylyk, B
    Weiss, E
    JOURNAL OF MOLECULAR RECOGNITION, 1999, 12 (02) : 141 - 152
  • [34] Activities of human papillomavirus 16 E6 natural variants in human keratinocytes
    Asadurian, Yulia
    Kurilin, Helena
    Lichtig, Hava
    Jackman, Anna
    Gonen, Pinhas
    Tommasino, Massimo
    Zehbe, Ingeborg
    Sherman, Levana
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (11) : 1751 - 1760
  • [35] Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis
    Seewaldt, VL
    Mrózek, K
    Dietze, EC
    Parker, M
    Caldwell, LE
    CANCER RESEARCH, 2001, 61 (02) : 616 - 624
  • [36] Spontaneous mutation of p53 gene in human papillomavirus type 16 E7-immortalized human laryngeal epithelial cells
    Suzuki, T
    Tsutsumi, K
    Nakajima, T
    Hara, F
    Kikuchi, K
    Yasumoto, S
    ACTA OTO-LARYNGOLOGICA, 1996, : 94 - 98
  • [37] p53-dependent and -independent transactivation by the E6 protein of human papillomavirus type 16
    Akutsu, N
    Shirasawa, H
    Asano, T
    Isono, K
    Simizu, B
    JOURNAL OF GENERAL VIROLOGY, 1996, 77 : 459 - 463
  • [38] Beta Human Papillomavirus E6 Expression Inhibits Stabilization of p53 and Increases Tolerance of Genomic Instability
    Wallace, Nicholas A.
    Robinson, Kristin
    Galloway, Denise A.
    JOURNAL OF VIROLOGY, 2014, 88 (11) : 6112 - 6127
  • [39] REPRESSION OF ENDOGENOUS P53 TRANSACTIVATION FUNCTION IN HELA CERVICAL-CARCINOMA CELLS BY HUMAN PAPILLOMAVIRUS TYPE-16 E6, HUMAN MDM-2, AND MUTANT P53
    HOPPESEYLER, F
    BUTZ, K
    JOURNAL OF VIROLOGY, 1993, 67 (06) : 3111 - 3117
  • [40] Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation
    Cheng, Ya-Wen
    Wu, Nling-Fang
    Wang, John
    Yeh, Kun-Tu
    Goan, Yih-Gang
    Chiou, Hui-Ling
    Chen, Chih-Yi
    Lee, Huei
    CANCER RESEARCH, 2007, 67 (22) : 10686 - 10693